Garfield Alastair 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Garfield Alastair
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2025-02-14+26,650→ 26,650 total→ Common Stock (26,650 underlying) - Award
Stock Options (Right to Buy)
2025-02-14+40,000→ 40,000 totalExercise: $56.69Exp: 2035-02-13→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.
- [F3]The options vest and become exercisable, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date, as to 6.25% of the total number of shares of common stock subject to the options upon the Reporting Person's completion of each successive three months of service to the Issuer after February 14, 2025, such that the option shall be fully vested and exercisable on February 14, 2029.